Global Typhoid Fever Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Typhoid fever is contracted by drinking or eating the Salmonella bacteria in contaminated food or water. Typhoid Fever Vaccines prevent typhoid fever and provide protection against it.
LPI (LP Information)' newest research report, the “Typhoid Fever Vaccines Industry Forecast” looks at past sales and reviews total world Typhoid Fever Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Typhoid Fever Vaccines sales for 2023 through 2029. With Typhoid Fever Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Typhoid Fever Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Typhoid Fever Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Typhoid Fever Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Typhoid Fever Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Typhoid Fever Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Typhoid Fever Vaccines.
The global Typhoid Fever Vaccines market size is projected to grow from US$ 206.8 million in 2022 to US$ 330.9 million in 2029; it is expected to grow at a CAGR of 330.9 from 2023 to 2029.
United States market for Typhoid Fever Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Typhoid Fever Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Typhoid Fever Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Typhoid Fever Vaccines players cover Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, PaxVax, Biomed, Prokarium and China National Biotec Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Typhoid Fever Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Typhoid Fever Vaccines market?
What factors are driving Typhoid Fever Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Typhoid Fever Vaccines market opportunities vary by end market size?
How does Typhoid Fever Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Typhoid fever is contracted by drinking or eating the Salmonella bacteria in contaminated food or water. Typhoid Fever Vaccines prevent typhoid fever and provide protection against it.
LPI (LP Information)' newest research report, the “Typhoid Fever Vaccines Industry Forecast” looks at past sales and reviews total world Typhoid Fever Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Typhoid Fever Vaccines sales for 2023 through 2029. With Typhoid Fever Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Typhoid Fever Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Typhoid Fever Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Typhoid Fever Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Typhoid Fever Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Typhoid Fever Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Typhoid Fever Vaccines.
The global Typhoid Fever Vaccines market size is projected to grow from US$ 206.8 million in 2022 to US$ 330.9 million in 2029; it is expected to grow at a CAGR of 330.9 from 2023 to 2029.
United States market for Typhoid Fever Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Typhoid Fever Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Typhoid Fever Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Typhoid Fever Vaccines players cover Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, PaxVax, Biomed, Prokarium and China National Biotec Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Typhoid Fever Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Live Attenuated Vaccine
- Conjugate Vaccine
- Capsular Polysaccharide Vaccines
- Others
- Government Institution
- Private Sector
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur
- GlaxoSmithKline
- Bharat Biotech
- PaxVax
- Biomed
- Prokarium
- China National Biotec Group
What is the 10-year outlook for the global Typhoid Fever Vaccines market?
What factors are driving Typhoid Fever Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Typhoid Fever Vaccines market opportunities vary by end market size?
How does Typhoid Fever Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Typhoid Fever Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Typhoid Fever Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Typhoid Fever Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Typhoid Fever Vaccines Segment by Type
2.2.1 Live Attenuated Vaccine
2.2.2 Conjugate Vaccine
2.2.3 Capsular Polysaccharide Vaccines
2.2.4 Others
2.3 Typhoid Fever Vaccines Sales by Type
2.3.1 Global Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Typhoid Fever Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Typhoid Fever Vaccines Sale Price by Type (2018-2023)
2.4 Typhoid Fever Vaccines Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.5 Typhoid Fever Vaccines Sales by Application
2.5.1 Global Typhoid Fever Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Typhoid Fever Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Typhoid Fever Vaccines Sale Price by Application (2018-2023)
3 GLOBAL TYPHOID FEVER VACCINES BY COMPANY
3.1 Global Typhoid Fever Vaccines Breakdown Data by Company
3.1.1 Global Typhoid Fever Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Typhoid Fever Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Typhoid Fever Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Typhoid Fever Vaccines Revenue by Company (2018-2023)
3.2.2 Global Typhoid Fever Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Typhoid Fever Vaccines Sale Price by Company
3.4 Key Manufacturers Typhoid Fever Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Typhoid Fever Vaccines Product Location Distribution
3.4.2 Players Typhoid Fever Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TYPHOID FEVER VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Typhoid Fever Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Typhoid Fever Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Typhoid Fever Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Typhoid Fever Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Typhoid Fever Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Typhoid Fever Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Typhoid Fever Vaccines Sales Growth
4.4 APAC Typhoid Fever Vaccines Sales Growth
4.5 Europe Typhoid Fever Vaccines Sales Growth
4.6 Middle East & Africa Typhoid Fever Vaccines Sales Growth
5 AMERICAS
5.1 Americas Typhoid Fever Vaccines Sales by Country
5.1.1 Americas Typhoid Fever Vaccines Sales by Country (2018-2023)
5.1.2 Americas Typhoid Fever Vaccines Revenue by Country (2018-2023)
5.2 Americas Typhoid Fever Vaccines Sales by Type
5.3 Americas Typhoid Fever Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Typhoid Fever Vaccines Sales by Region
6.1.1 APAC Typhoid Fever Vaccines Sales by Region (2018-2023)
6.1.2 APAC Typhoid Fever Vaccines Revenue by Region (2018-2023)
6.2 APAC Typhoid Fever Vaccines Sales by Type
6.3 APAC Typhoid Fever Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Typhoid Fever Vaccines by Country
7.1.1 Europe Typhoid Fever Vaccines Sales by Country (2018-2023)
7.1.2 Europe Typhoid Fever Vaccines Revenue by Country (2018-2023)
7.2 Europe Typhoid Fever Vaccines Sales by Type
7.3 Europe Typhoid Fever Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Typhoid Fever Vaccines by Country
8.1.1 Middle East & Africa Typhoid Fever Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Typhoid Fever Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Typhoid Fever Vaccines Sales by Type
8.3 Middle East & Africa Typhoid Fever Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Typhoid Fever Vaccines
10.3 Manufacturing Process Analysis of Typhoid Fever Vaccines
10.4 Industry Chain Structure of Typhoid Fever Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Typhoid Fever Vaccines Distributors
11.3 Typhoid Fever Vaccines Customer
12 WORLD FORECAST REVIEW FOR TYPHOID FEVER VACCINES BY GEOGRAPHIC REGION
12.1 Global Typhoid Fever Vaccines Market Size Forecast by Region
12.1.1 Global Typhoid Fever Vaccines Forecast by Region (2024-2029)
12.1.2 Global Typhoid Fever Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Typhoid Fever Vaccines Forecast by Type
12.7 Global Typhoid Fever Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Typhoid Fever Vaccines Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Typhoid Fever Vaccines Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Typhoid Fever Vaccines Product Portfolios and Specifications
13.3.3 Bharat Biotech Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 PaxVax
13.4.1 PaxVax Company Information
13.4.2 PaxVax Typhoid Fever Vaccines Product Portfolios and Specifications
13.4.3 PaxVax Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 PaxVax Main Business Overview
13.4.5 PaxVax Latest Developments
13.5 Biomed
13.5.1 Biomed Company Information
13.5.2 Biomed Typhoid Fever Vaccines Product Portfolios and Specifications
13.5.3 Biomed Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biomed Main Business Overview
13.5.5 Biomed Latest Developments
13.6 Prokarium
13.6.1 Prokarium Company Information
13.6.2 Prokarium Typhoid Fever Vaccines Product Portfolios and Specifications
13.6.3 Prokarium Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Prokarium Main Business Overview
13.6.5 Prokarium Latest Developments
13.7 China National Biotec Group
13.7.1 China National Biotec Group Company Information
13.7.2 China National Biotec Group Typhoid Fever Vaccines Product Portfolios and Specifications
13.7.3 China National Biotec Group Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 China National Biotec Group Main Business Overview
13.7.5 China National Biotec Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Typhoid Fever Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Typhoid Fever Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Typhoid Fever Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Typhoid Fever Vaccines Segment by Type
2.2.1 Live Attenuated Vaccine
2.2.2 Conjugate Vaccine
2.2.3 Capsular Polysaccharide Vaccines
2.2.4 Others
2.3 Typhoid Fever Vaccines Sales by Type
2.3.1 Global Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Typhoid Fever Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Typhoid Fever Vaccines Sale Price by Type (2018-2023)
2.4 Typhoid Fever Vaccines Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.5 Typhoid Fever Vaccines Sales by Application
2.5.1 Global Typhoid Fever Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Typhoid Fever Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Typhoid Fever Vaccines Sale Price by Application (2018-2023)
3 GLOBAL TYPHOID FEVER VACCINES BY COMPANY
3.1 Global Typhoid Fever Vaccines Breakdown Data by Company
3.1.1 Global Typhoid Fever Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Typhoid Fever Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Typhoid Fever Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Typhoid Fever Vaccines Revenue by Company (2018-2023)
3.2.2 Global Typhoid Fever Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Typhoid Fever Vaccines Sale Price by Company
3.4 Key Manufacturers Typhoid Fever Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Typhoid Fever Vaccines Product Location Distribution
3.4.2 Players Typhoid Fever Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TYPHOID FEVER VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Typhoid Fever Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Typhoid Fever Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Typhoid Fever Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Typhoid Fever Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Typhoid Fever Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Typhoid Fever Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Typhoid Fever Vaccines Sales Growth
4.4 APAC Typhoid Fever Vaccines Sales Growth
4.5 Europe Typhoid Fever Vaccines Sales Growth
4.6 Middle East & Africa Typhoid Fever Vaccines Sales Growth
5 AMERICAS
5.1 Americas Typhoid Fever Vaccines Sales by Country
5.1.1 Americas Typhoid Fever Vaccines Sales by Country (2018-2023)
5.1.2 Americas Typhoid Fever Vaccines Revenue by Country (2018-2023)
5.2 Americas Typhoid Fever Vaccines Sales by Type
5.3 Americas Typhoid Fever Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Typhoid Fever Vaccines Sales by Region
6.1.1 APAC Typhoid Fever Vaccines Sales by Region (2018-2023)
6.1.2 APAC Typhoid Fever Vaccines Revenue by Region (2018-2023)
6.2 APAC Typhoid Fever Vaccines Sales by Type
6.3 APAC Typhoid Fever Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Typhoid Fever Vaccines by Country
7.1.1 Europe Typhoid Fever Vaccines Sales by Country (2018-2023)
7.1.2 Europe Typhoid Fever Vaccines Revenue by Country (2018-2023)
7.2 Europe Typhoid Fever Vaccines Sales by Type
7.3 Europe Typhoid Fever Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Typhoid Fever Vaccines by Country
8.1.1 Middle East & Africa Typhoid Fever Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Typhoid Fever Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Typhoid Fever Vaccines Sales by Type
8.3 Middle East & Africa Typhoid Fever Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Typhoid Fever Vaccines
10.3 Manufacturing Process Analysis of Typhoid Fever Vaccines
10.4 Industry Chain Structure of Typhoid Fever Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Typhoid Fever Vaccines Distributors
11.3 Typhoid Fever Vaccines Customer
12 WORLD FORECAST REVIEW FOR TYPHOID FEVER VACCINES BY GEOGRAPHIC REGION
12.1 Global Typhoid Fever Vaccines Market Size Forecast by Region
12.1.1 Global Typhoid Fever Vaccines Forecast by Region (2024-2029)
12.1.2 Global Typhoid Fever Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Typhoid Fever Vaccines Forecast by Type
12.7 Global Typhoid Fever Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Typhoid Fever Vaccines Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Information
13.2.2 GlaxoSmithKline Typhoid Fever Vaccines Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GlaxoSmithKline Main Business Overview
13.2.5 GlaxoSmithKline Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Typhoid Fever Vaccines Product Portfolios and Specifications
13.3.3 Bharat Biotech Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 PaxVax
13.4.1 PaxVax Company Information
13.4.2 PaxVax Typhoid Fever Vaccines Product Portfolios and Specifications
13.4.3 PaxVax Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 PaxVax Main Business Overview
13.4.5 PaxVax Latest Developments
13.5 Biomed
13.5.1 Biomed Company Information
13.5.2 Biomed Typhoid Fever Vaccines Product Portfolios and Specifications
13.5.3 Biomed Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biomed Main Business Overview
13.5.5 Biomed Latest Developments
13.6 Prokarium
13.6.1 Prokarium Company Information
13.6.2 Prokarium Typhoid Fever Vaccines Product Portfolios and Specifications
13.6.3 Prokarium Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Prokarium Main Business Overview
13.6.5 Prokarium Latest Developments
13.7 China National Biotec Group
13.7.1 China National Biotec Group Company Information
13.7.2 China National Biotec Group Typhoid Fever Vaccines Product Portfolios and Specifications
13.7.3 China National Biotec Group Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 China National Biotec Group Main Business Overview
13.7.5 China National Biotec Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Typhoid Fever Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Typhoid Fever Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccine
Table 4. Major Players of Conjugate Vaccine
Table 5. Major Players of Capsular Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Typhoid Fever Vaccines Sales by Type (2018-2023) & (K Doses)
Table 8. Global Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
Table 9. Global Typhoid Fever Vaccines Revenue by Type (2018-2023) & ($ million)
Table 10. Global Typhoid Fever Vaccines Revenue Market Share by Type (2018-2023)
Table 11. Global Typhoid Fever Vaccines Sale Price by Type (2018-2023) & (USD/Dose)
Table 12. Global Typhoid Fever Vaccines Sales by Application (2018-2023) & (K Doses)
Table 13. Global Typhoid Fever Vaccines Sales Market Share by Application (2018-2023)
Table 14. Global Typhoid Fever Vaccines Revenue by Application (2018-2023)
Table 15. Global Typhoid Fever Vaccines Revenue Market Share by Application (2018-2023)
Table 16. Global Typhoid Fever Vaccines Sale Price by Application (2018-2023) & (USD/Dose)
Table 17. Global Typhoid Fever Vaccines Sales by Company (2018-2023) & (K Doses)
Table 18. Global Typhoid Fever Vaccines Sales Market Share by Company (2018-2023)
Table 19. Global Typhoid Fever Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Typhoid Fever Vaccines Revenue Market Share by Company (2018-2023)
Table 21. Global Typhoid Fever Vaccines Sale Price by Company (2018-2023) & (USD/Dose)
Table 22. Key Manufacturers Typhoid Fever Vaccines Producing Area Distribution and Sales Area
Table 23. Players Typhoid Fever Vaccines Products Offered
Table 24. Typhoid Fever Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Typhoid Fever Vaccines Sales by Geographic Region (2018-2023) & (K Doses)
Table 28. Global Typhoid Fever Vaccines Sales Market Share Geographic Region (2018-2023)
Table 29. Global Typhoid Fever Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Typhoid Fever Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Typhoid Fever Vaccines Sales by Country/Region (2018-2023) & (K Doses)
Table 32. Global Typhoid Fever Vaccines Sales Market Share by Country/Region (2018-2023)
Table 33. Global Typhoid Fever Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Typhoid Fever Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Typhoid Fever Vaccines Sales by Country (2018-2023) & (K Doses)
Table 36. Americas Typhoid Fever Vaccines Sales Market Share by Country (2018-2023)
Table 37. Americas Typhoid Fever Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Typhoid Fever Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Americas Typhoid Fever Vaccines Sales by Type (2018-2023) & (K Doses)
Table 40. Americas Typhoid Fever Vaccines Sales by Application (2018-2023) & (K Doses)
Table 41. APAC Typhoid Fever Vaccines Sales by Region (2018-2023) & (K Doses)
Table 42. APAC Typhoid Fever Vaccines Sales Market Share by Region (2018-2023)
Table 43. APAC Typhoid Fever Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Typhoid Fever Vaccines Revenue Market Share by Region (2018-2023)
Table 45. APAC Typhoid Fever Vaccines Sales by Type (2018-2023) & (K Doses)
Table 46. APAC Typhoid Fever Vaccines Sales by Application (2018-2023) & (K Doses)
Table 47. Europe Typhoid Fever Vaccines Sales by Country (2018-2023) & (K Doses)
Table 48. Europe Typhoid Fever Vaccines Sales Market Share by Country (2018-2023)
Table 49. Europe Typhoid Fever Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Typhoid Fever Vaccines Revenue Market Share by Country (2018-2023)
Table 51. Europe Typhoid Fever Vaccines Sales by Type (2018-2023) & (K Doses)
Table 52. Europe Typhoid Fever Vaccines Sales by Application (2018-2023) & (K Doses)
Table 53. Middle East & Africa Typhoid Fever Vaccines Sales by Country (2018-2023) & (K Doses)
Table 54. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Typhoid Fever Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Typhoid Fever Vaccines Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Typhoid Fever Vaccines Sales by Type (2018-2023) & (K Doses)
Table 58. Middle East & Africa Typhoid Fever Vaccines Sales by Application (2018-2023) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of Typhoid Fever Vaccines
Table 60. Key Market Challenges & Risks of Typhoid Fever Vaccines
Table 61. Key Industry Trends of Typhoid Fever Vaccines
Table 62. Typhoid Fever Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Typhoid Fever Vaccines Distributors List
Table 65. Typhoid Fever Vaccines Customer List
Table 66. Global Typhoid Fever Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 67. Global Typhoid Fever Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Typhoid Fever Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 69. Americas Typhoid Fever Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Typhoid Fever Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 71. APAC Typhoid Fever Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Typhoid Fever Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Europe Typhoid Fever Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Typhoid Fever Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Middle East & Africa Typhoid Fever Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Typhoid Fever Vaccines Sales Forecast by Type (2024-2029) & (K Doses)
Table 77. Global Typhoid Fever Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Typhoid Fever Vaccines Sales Forecast by Application (2024-2029) & (K Doses)
Table 79. Global Typhoid Fever Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Sanofi Pasteur Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. Sanofi Pasteur Typhoid Fever Vaccines Product Portfolios and Specifications
Table 82. Sanofi Pasteur Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 83. Sanofi Pasteur Main Business
Table 84. Sanofi Pasteur Latest Developments
Table 85. GlaxoSmithKline Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. GlaxoSmithKline Typhoid Fever Vaccines Product Portfolios and Specifications
Table 87. GlaxoSmithKline Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 88. GlaxoSmithKline Main Business
Table 89. GlaxoSmithKline Latest Developments
Table 90. Bharat Biotech Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Bharat Biotech Typhoid Fever Vaccines Product Portfolios and Specifications
Table 92. Bharat Biotech Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 93. Bharat Biotech Main Business
Table 94. Bharat Biotech Latest Developments
Table 95. PaxVax Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. PaxVax Typhoid Fever Vaccines Product Portfolios and Specifications
Table 97. PaxVax Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 98. PaxVax Main Business
Table 99. PaxVax Latest Developments
Table 100. Biomed Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Biomed Typhoid Fever Vaccines Product Portfolios and Specifications
Table 102. Biomed Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 103. Biomed Main Business
Table 104. Biomed Latest Developments
Table 105. Prokarium Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Prokarium Typhoid Fever Vaccines Product Portfolios and Specifications
Table 107. Prokarium Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 108. Prokarium Main Business
Table 109. Prokarium Latest Developments
Table 110. China National Biotec Group Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. China National Biotec Group Typhoid Fever Vaccines Product Portfolios and Specifications
Table 112. China National Biotec Group Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 113. China National Biotec Group Main Business
Table 114. China National Biotec Group Latest Developments
Table 1. Typhoid Fever Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Typhoid Fever Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccine
Table 4. Major Players of Conjugate Vaccine
Table 5. Major Players of Capsular Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Typhoid Fever Vaccines Sales by Type (2018-2023) & (K Doses)
Table 8. Global Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
Table 9. Global Typhoid Fever Vaccines Revenue by Type (2018-2023) & ($ million)
Table 10. Global Typhoid Fever Vaccines Revenue Market Share by Type (2018-2023)
Table 11. Global Typhoid Fever Vaccines Sale Price by Type (2018-2023) & (USD/Dose)
Table 12. Global Typhoid Fever Vaccines Sales by Application (2018-2023) & (K Doses)
Table 13. Global Typhoid Fever Vaccines Sales Market Share by Application (2018-2023)
Table 14. Global Typhoid Fever Vaccines Revenue by Application (2018-2023)
Table 15. Global Typhoid Fever Vaccines Revenue Market Share by Application (2018-2023)
Table 16. Global Typhoid Fever Vaccines Sale Price by Application (2018-2023) & (USD/Dose)
Table 17. Global Typhoid Fever Vaccines Sales by Company (2018-2023) & (K Doses)
Table 18. Global Typhoid Fever Vaccines Sales Market Share by Company (2018-2023)
Table 19. Global Typhoid Fever Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Typhoid Fever Vaccines Revenue Market Share by Company (2018-2023)
Table 21. Global Typhoid Fever Vaccines Sale Price by Company (2018-2023) & (USD/Dose)
Table 22. Key Manufacturers Typhoid Fever Vaccines Producing Area Distribution and Sales Area
Table 23. Players Typhoid Fever Vaccines Products Offered
Table 24. Typhoid Fever Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Typhoid Fever Vaccines Sales by Geographic Region (2018-2023) & (K Doses)
Table 28. Global Typhoid Fever Vaccines Sales Market Share Geographic Region (2018-2023)
Table 29. Global Typhoid Fever Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Typhoid Fever Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Typhoid Fever Vaccines Sales by Country/Region (2018-2023) & (K Doses)
Table 32. Global Typhoid Fever Vaccines Sales Market Share by Country/Region (2018-2023)
Table 33. Global Typhoid Fever Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Typhoid Fever Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Typhoid Fever Vaccines Sales by Country (2018-2023) & (K Doses)
Table 36. Americas Typhoid Fever Vaccines Sales Market Share by Country (2018-2023)
Table 37. Americas Typhoid Fever Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Typhoid Fever Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Americas Typhoid Fever Vaccines Sales by Type (2018-2023) & (K Doses)
Table 40. Americas Typhoid Fever Vaccines Sales by Application (2018-2023) & (K Doses)
Table 41. APAC Typhoid Fever Vaccines Sales by Region (2018-2023) & (K Doses)
Table 42. APAC Typhoid Fever Vaccines Sales Market Share by Region (2018-2023)
Table 43. APAC Typhoid Fever Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Typhoid Fever Vaccines Revenue Market Share by Region (2018-2023)
Table 45. APAC Typhoid Fever Vaccines Sales by Type (2018-2023) & (K Doses)
Table 46. APAC Typhoid Fever Vaccines Sales by Application (2018-2023) & (K Doses)
Table 47. Europe Typhoid Fever Vaccines Sales by Country (2018-2023) & (K Doses)
Table 48. Europe Typhoid Fever Vaccines Sales Market Share by Country (2018-2023)
Table 49. Europe Typhoid Fever Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Typhoid Fever Vaccines Revenue Market Share by Country (2018-2023)
Table 51. Europe Typhoid Fever Vaccines Sales by Type (2018-2023) & (K Doses)
Table 52. Europe Typhoid Fever Vaccines Sales by Application (2018-2023) & (K Doses)
Table 53. Middle East & Africa Typhoid Fever Vaccines Sales by Country (2018-2023) & (K Doses)
Table 54. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Typhoid Fever Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Typhoid Fever Vaccines Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Typhoid Fever Vaccines Sales by Type (2018-2023) & (K Doses)
Table 58. Middle East & Africa Typhoid Fever Vaccines Sales by Application (2018-2023) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of Typhoid Fever Vaccines
Table 60. Key Market Challenges & Risks of Typhoid Fever Vaccines
Table 61. Key Industry Trends of Typhoid Fever Vaccines
Table 62. Typhoid Fever Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Typhoid Fever Vaccines Distributors List
Table 65. Typhoid Fever Vaccines Customer List
Table 66. Global Typhoid Fever Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 67. Global Typhoid Fever Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Typhoid Fever Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 69. Americas Typhoid Fever Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Typhoid Fever Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 71. APAC Typhoid Fever Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Typhoid Fever Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Europe Typhoid Fever Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Typhoid Fever Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Middle East & Africa Typhoid Fever Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Typhoid Fever Vaccines Sales Forecast by Type (2024-2029) & (K Doses)
Table 77. Global Typhoid Fever Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Typhoid Fever Vaccines Sales Forecast by Application (2024-2029) & (K Doses)
Table 79. Global Typhoid Fever Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Sanofi Pasteur Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. Sanofi Pasteur Typhoid Fever Vaccines Product Portfolios and Specifications
Table 82. Sanofi Pasteur Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 83. Sanofi Pasteur Main Business
Table 84. Sanofi Pasteur Latest Developments
Table 85. GlaxoSmithKline Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. GlaxoSmithKline Typhoid Fever Vaccines Product Portfolios and Specifications
Table 87. GlaxoSmithKline Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 88. GlaxoSmithKline Main Business
Table 89. GlaxoSmithKline Latest Developments
Table 90. Bharat Biotech Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Bharat Biotech Typhoid Fever Vaccines Product Portfolios and Specifications
Table 92. Bharat Biotech Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 93. Bharat Biotech Main Business
Table 94. Bharat Biotech Latest Developments
Table 95. PaxVax Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. PaxVax Typhoid Fever Vaccines Product Portfolios and Specifications
Table 97. PaxVax Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 98. PaxVax Main Business
Table 99. PaxVax Latest Developments
Table 100. Biomed Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Biomed Typhoid Fever Vaccines Product Portfolios and Specifications
Table 102. Biomed Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 103. Biomed Main Business
Table 104. Biomed Latest Developments
Table 105. Prokarium Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Prokarium Typhoid Fever Vaccines Product Portfolios and Specifications
Table 107. Prokarium Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 108. Prokarium Main Business
Table 109. Prokarium Latest Developments
Table 110. China National Biotec Group Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. China National Biotec Group Typhoid Fever Vaccines Product Portfolios and Specifications
Table 112. China National Biotec Group Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 113. China National Biotec Group Main Business
Table 114. China National Biotec Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Typhoid Fever Vaccines
Figure 2. Typhoid Fever Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Typhoid Fever Vaccines Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Typhoid Fever Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Typhoid Fever Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live Attenuated Vaccine
Figure 10. Product Picture of Conjugate Vaccine
Figure 11. Product Picture of Capsular Polysaccharide Vaccines
Figure 12. Product Picture of Others
Figure 13. Global Typhoid Fever Vaccines Sales Market Share by Type in 2022
Figure 14. Global Typhoid Fever Vaccines Revenue Market Share by Type (2018-2023)
Figure 15. Typhoid Fever Vaccines Consumed in Government Institution
Figure 16. Global Typhoid Fever Vaccines Market: Government Institution (2018-2023) & (K Doses)
Figure 17. Typhoid Fever Vaccines Consumed in Private Sector
Figure 18. Global Typhoid Fever Vaccines Market: Private Sector (2018-2023) & (K Doses)
Figure 19. Global Typhoid Fever Vaccines Sales Market Share by Application (2022)
Figure 20. Global Typhoid Fever Vaccines Revenue Market Share by Application in 2022
Figure 21. Typhoid Fever Vaccines Sales Market by Company in 2022 (K Doses)
Figure 22. Global Typhoid Fever Vaccines Sales Market Share by Company in 2022
Figure 23. Typhoid Fever Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Typhoid Fever Vaccines Revenue Market Share by Company in 2022
Figure 25. Global Typhoid Fever Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Typhoid Fever Vaccines Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Typhoid Fever Vaccines Sales 2018-2023 (K Doses)
Figure 28. Americas Typhoid Fever Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. APAC Typhoid Fever Vaccines Sales 2018-2023 (K Doses)
Figure 30. APAC Typhoid Fever Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Europe Typhoid Fever Vaccines Sales 2018-2023 (K Doses)
Figure 32. Europe Typhoid Fever Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Typhoid Fever Vaccines Sales 2018-2023 (K Doses)
Figure 34. Middle East & Africa Typhoid Fever Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Americas Typhoid Fever Vaccines Sales Market Share by Country in 2022
Figure 36. Americas Typhoid Fever Vaccines Revenue Market Share by Country in 2022
Figure 37. Americas Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
Figure 38. Americas Typhoid Fever Vaccines Sales Market Share by Application (2018-2023)
Figure 39. United States Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Typhoid Fever Vaccines Sales Market Share by Region in 2022
Figure 44. APAC Typhoid Fever Vaccines Revenue Market Share by Regions in 2022
Figure 45. APAC Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
Figure 46. APAC Typhoid Fever Vaccines Sales Market Share by Application (2018-2023)
Figure 47. China Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Typhoid Fever Vaccines Sales Market Share by Country in 2022
Figure 55. Europe Typhoid Fever Vaccines Revenue Market Share by Country in 2022
Figure 56. Europe Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
Figure 57. Europe Typhoid Fever Vaccines Sales Market Share by Application (2018-2023)
Figure 58. Germany Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Typhoid Fever Vaccines Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Application (2018-2023)
Figure 67. Egypt Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Typhoid Fever Vaccines in 2022
Figure 73. Manufacturing Process Analysis of Typhoid Fever Vaccines
Figure 74. Industry Chain Structure of Typhoid Fever Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Typhoid Fever Vaccines Sales Market Forecast by Region (2024-2029)
Figure 77. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Typhoid Fever Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Typhoid Fever Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Typhoid Fever Vaccines
Figure 2. Typhoid Fever Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Typhoid Fever Vaccines Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Typhoid Fever Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Typhoid Fever Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live Attenuated Vaccine
Figure 10. Product Picture of Conjugate Vaccine
Figure 11. Product Picture of Capsular Polysaccharide Vaccines
Figure 12. Product Picture of Others
Figure 13. Global Typhoid Fever Vaccines Sales Market Share by Type in 2022
Figure 14. Global Typhoid Fever Vaccines Revenue Market Share by Type (2018-2023)
Figure 15. Typhoid Fever Vaccines Consumed in Government Institution
Figure 16. Global Typhoid Fever Vaccines Market: Government Institution (2018-2023) & (K Doses)
Figure 17. Typhoid Fever Vaccines Consumed in Private Sector
Figure 18. Global Typhoid Fever Vaccines Market: Private Sector (2018-2023) & (K Doses)
Figure 19. Global Typhoid Fever Vaccines Sales Market Share by Application (2022)
Figure 20. Global Typhoid Fever Vaccines Revenue Market Share by Application in 2022
Figure 21. Typhoid Fever Vaccines Sales Market by Company in 2022 (K Doses)
Figure 22. Global Typhoid Fever Vaccines Sales Market Share by Company in 2022
Figure 23. Typhoid Fever Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Typhoid Fever Vaccines Revenue Market Share by Company in 2022
Figure 25. Global Typhoid Fever Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Typhoid Fever Vaccines Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Typhoid Fever Vaccines Sales 2018-2023 (K Doses)
Figure 28. Americas Typhoid Fever Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. APAC Typhoid Fever Vaccines Sales 2018-2023 (K Doses)
Figure 30. APAC Typhoid Fever Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Europe Typhoid Fever Vaccines Sales 2018-2023 (K Doses)
Figure 32. Europe Typhoid Fever Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Typhoid Fever Vaccines Sales 2018-2023 (K Doses)
Figure 34. Middle East & Africa Typhoid Fever Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Americas Typhoid Fever Vaccines Sales Market Share by Country in 2022
Figure 36. Americas Typhoid Fever Vaccines Revenue Market Share by Country in 2022
Figure 37. Americas Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
Figure 38. Americas Typhoid Fever Vaccines Sales Market Share by Application (2018-2023)
Figure 39. United States Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Typhoid Fever Vaccines Sales Market Share by Region in 2022
Figure 44. APAC Typhoid Fever Vaccines Revenue Market Share by Regions in 2022
Figure 45. APAC Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
Figure 46. APAC Typhoid Fever Vaccines Sales Market Share by Application (2018-2023)
Figure 47. China Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Typhoid Fever Vaccines Sales Market Share by Country in 2022
Figure 55. Europe Typhoid Fever Vaccines Revenue Market Share by Country in 2022
Figure 56. Europe Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
Figure 57. Europe Typhoid Fever Vaccines Sales Market Share by Application (2018-2023)
Figure 58. Germany Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Typhoid Fever Vaccines Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Application (2018-2023)
Figure 67. Egypt Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Typhoid Fever Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Typhoid Fever Vaccines in 2022
Figure 73. Manufacturing Process Analysis of Typhoid Fever Vaccines
Figure 74. Industry Chain Structure of Typhoid Fever Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Typhoid Fever Vaccines Sales Market Forecast by Region (2024-2029)
Figure 77. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Typhoid Fever Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Typhoid Fever Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Application (2024-2029)
